Article info

Download PDFPDF

Original article
Immune activation by DNA damage predicts response to chemotherapy and survival in oesophageal adenocarcinoma

Authors

  1. Correspondence to Dr Richard C Turkington, Centre for Cancer Research and Cell Biology, Queen’s University Belfast, Belfast, BT9 7BL, UK; r.turkington{at}qub.ac.uk
View Full Text

Citation

Turkington RC, Knight LA, Blayney JK on behalf of the Oesophageal Cancer Clinical and Molecular Stratification (OCCAMS) Study Group, et al
Immune activation by DNA damage predicts response to chemotherapy and survival in oesophageal adenocarcinoma

Publication history

  • Received September 19, 2018
  • Revised February 13, 2019
  • Accepted February 15, 2019
  • First published March 9, 2019.

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.